Kombo knife combined with sorafenib in liver cancer treatment: Efficacy and safety under immune function influence

Table 2 Details of the comparison of the efficacy of the three groups of patients, n (%)

Efficacy	Combo knife	Combo knife + sorafenib group	TACE + sorafenib
CR	1 (3.1)	1 (3.1)	0 (0.0)
PR	18 (56.3)	20 (62.5)	15 (46.9)
SD	9 (28.1)	8 (25.0)	10 (31.3)
PD	4 (12.5)	3 (9.4)	7 (21.8)
ORR	59.4	65.6	46.9
DCR	87.5	90.6	78.7

CR: Complete remission; PR: Partial remission; SD: Stable disease; PD: Progressive disease; ORR: Objective response rate; DCR: Disease control rate; TACE: Transarterial chemoembolization.